Benefits of bifidobacterium breve M-16V Supplementation in preterm neonates -A retrospective cohort study

    Research output: Contribution to journalArticle

    30 Citations (Scopus)

    Abstract

    © 2016 Patole et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Background Systematic reviews of randomised controlled trials report that probiotics reduce the risk of necrotising enterocolitis (NEC) in preterm neonates. Aim To determine whether routine probiotic supplementation (RPS) to preterm neonates would reduce the incidence of NEC. Methods The incidence of NEC = Stage II and all-cause mortality was compared for an equal period of 24 months 'before' (Epoch 1) and 'after' (Epoch 2) RPS with Bifidobacterium breve M-16V in neonates
    Original languageEnglish
    Article numbere0150775
    JournalPLoS One
    Volume11
    Issue number3
    DOIs
    Publication statusPublished - 2016

      Fingerprint

    Cite this